Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
出版年份 2023 全文链接
标题
Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
作者
关键词
-
出版物
Biomedicines
Volume 11, Issue 6, Pages 1610
出版商
MDPI AG
发表日期
2023-06-02
DOI
10.3390/biomedicines11061610
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer
- (2022) Shiming He et al. DRUG DELIVERY
- CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer
- (2022) Hongjia Zhu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy
- (2022) Dan Lu et al. Frontiers in Immunology
- Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells
- (2022) Jun-He Zhang et al. Frontiers in Bioengineering and Biotechnology
- Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma
- (2022) Godfrey Chi-Fung Chan et al. Biomolecules
- Epitope Mapping of Rituximab Using HisMAP Method
- (2022) Teizo Asano et al. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
- Mosunetuzumab: First Approval
- (2022) Connie Kang DRUGS
- Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance
- (2022) Xinlei Zhuang et al. Nature Communications
- The High-Resolution Structure Reveals Remarkable Similarity in PD-1 Binding of Cemiplimab and Dostarlimab, the FDA-Approved Antibodies for Cancer Immunotherapy
- (2022) Tae-Jun Jeong et al. Biomedicines
- Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple Myeloma
- (2021) Mariko Ishibashi et al. Cancers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
- (2021) Gilles Salles et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope
- (2021) Koki Makabe et al. Scientific Reports
- A single-chain antibody generation system yielding CAR-T cells with superior antitumor function
- (2021) Toshiki Ochi et al. Communications Biology
- Determination of the Rituximab Binding Site to the CD20 Epitope Using SPOT Synthesis and Surface Plasmon Resonance Analyses
- (2021) Laure Bar et al. ANALYTICAL CHEMISTRY
- CD70-specific CAR T-cells have potent activity against Acute Myeloid Leukemia (AML) without HSC toxicity
- (2021) Tim Sauer et al. BLOOD
- RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
- (2021) Chen-Chen Huang et al. BMC CANCER
- Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET
- (2021) Joost Neijssen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
- (2021) Robert L Coleman et al. LANCET ONCOLOGY
- Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis
- (2021) Kelly R. Cotchett et al. Multiple Sclerosis and Related Disorders
- Recombinant antibodies and their use for food immunoanalysis
- (2021) Riikka Peltomaa et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide
- (2021) Yu Du et al. ANTI-CANCER DRUGS
- Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety
- (2021) Massimo Offidani et al. Drug Design Development and Therapy
- A Cluster Analysis of Risk Factors for Cancer across EU Countries: Health Policy Recommendations for Prevention
- (2021) Dawid Majcherek et al. International Journal of Environmental Research and Public Health
- GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma
- (2021) Felix Zirngibl et al. Journal for ImmunoTherapy of Cancer
- Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma
- (2021) Pier Luigi Zinzani et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A method of delivering an anti-p21Ras single-chain antibody fragment to tumor sites in vivo
- (2021) Peng Wang et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy
- (2021) Zhaohuan Li et al. JOURNAL OF NANOBIOTECHNOLOGY
- Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models
- (2021) Hyeon Ho Lee et al. NEOPLASIA
- Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy
- (2021) Kajal H. Gupta et al. Vaccines
- Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2
- (2021) Meng Sun et al. iScience
- Molecular profiling for precision cancer therapies
- (2020) Eoghan R. Malone et al. Genome Medicine
- Epitope and Paratope Mapping of PD-1/Nivolumab by Mass Spectrometry-based Hydrogen/Deuterium Exchange, Cross-linking, and Molecular Docking
- (2020) Mengru Mira Zhang et al. ANALYTICAL CHEMISTRY
- Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells
- (2020) Behrad Darvishi et al. CELL BIOCHEMISTRY AND FUNCTION
- How to select IgG subclasses in developing anti-tumor therapeutic antibodies
- (2020) Jifeng Yu et al. Journal of Hematology & Oncology
- The world of cell penetrating: the future of medical applications
- (2020) Annarita Falanga et al. Future Medicinal Chemistry
- Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
- (2020) Laurène Fenwarth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Specific functions of Exostosin-like 3 (EXTL3) gene products
- (2020) Shuhei Yamada CELLULAR & MOLECULAR BIOLOGY LETTERS
- Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments
- (2020) Annamaria Sandomenico et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms
- (2020) Tae Hyun Kang et al. Frontiers in Microbiology
- Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab Vedotin
- (2020) Rohit K Jain et al. Cancer Management and Research
- Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma
- (2020) Kodandaram Pillarisetti et al. Blood Advances
- Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
- (2020) Hyun Tae Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Immunotherapy Advances for Epithelial Ovarian Cancer
- (2020) Erin G. Hartnett et al. Cancers
- Trends in Monoclonal Antibody Production Using Various Bioreactor Syst
- (2020) I. Jyothilekshmi et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies
- (2019) Joseph Tintelnot et al. MOLECULAR CANCER THERAPEUTICS
- A novel method for determining antibody-dependent cellular phagocytosis
- (2019) Lynn Kamen et al. JOURNAL OF IMMUNOLOGICAL METHODS
- CIK cell-based delivery of recombinant adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the anti-tumor effect and safety in lung cancer
- (2019) Xin-Rui Lin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A T-cell–engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer
- (2019) Akira Iizuka et al. CLINICAL CANCER RESEARCH
- Daratumumab in multiple myeloma
- (2019) Ajay K. Nooka et al. CANCER
- Efficient development and expression of scFv recombinant proteins against PD-L1 surface domain and potency in cancer therapy
- (2019) Muhammad Kalim et al. CYTOTECHNOLOGY
- Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody‐drug conjugate to enable clinical development of polatuzumab vedotin
- (2019) Dongwei Li et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
- (2019) Soichiro Yamauchi et al. MOLECULES
- Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
- (2019) Jesús García-Foncillas et al. Frontiers in Oncology
- Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer
- (2019) Ruei‐Min Lu et al. CANCER SCIENCE
- Mechanisms of Resistance to Monoclonal Antibodies (mAbs) in Lymphoid Malignancies
- (2019) Pallawi Torka et al. Current Hematologic Malignancy Reports
- Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
- (2019) Jiwon Koh et al. Biomolecules
- Crystal structure of B-cell co-receptor CD19 in complex with antibody B43 reveals an unexpected fold
- (2018) Alexey Teplyakov et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
- (2018) Gianluca Moroncini et al. OncoTargets and Therapy
- Anti-CD20 monoclonal antibodies: reviewing a revolution
- (2018) J. M. L. Casan et al. Human Vaccines & Immunotherapeutics
- Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells
- (2018) Fang-Rui Liu et al. BMC CANCER
- Moxetumomab Pasudotox: First Global Approval
- (2018) Sohita Dhillon DRUGS
- Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance
- (2017) Atrish Bagchi et al. MOLECULAR CANCER THERAPEUTICS
- Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer
- (2017) Xiaomin Liu et al. Oncotarget
- Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor/progenitor cells
- (2017) Ying Cao Cell and Bioscience
- Production of anti-amoxicillin ScFv antibody and simulation studying its molecular recognition mechanism for penicillins
- (2016) Jing Liu et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD CONTAMINANTS AND AGRICULTURAL WASTES
- Antibody–drug conjugates for cancer therapy
- (2016) Anish Thomas et al. LANCET ONCOLOGY
- Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity
- (2016) Madelon Q. Wentink et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies
- (2016) Ronald P. Taylor et al. SEMINARS IN IMMUNOLOGY
- Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
- (2015) S. Arena et al. CLINICAL CANCER RESEARCH
- FDA Approval: Blinatumomab
- (2015) D. Przepiorka et al. CLINICAL CANCER RESEARCH
- Fcγ receptor pathways during active and passive immunization
- (2015) Stylianos Bournazos et al. IMMUNOLOGICAL REVIEWS
- Influence of molecular size on tissue distribution of antibody fragments
- (2015) Zhe Li et al. mAbs
- Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
- (2015) Friederike Braig et al. Oncotarget
- Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity
- (2015) Robert G. E. Holgate et al. PLoS One
- Complement in monoclonal antibody therapy of cancer
- (2014) Laura M. Rogers et al. IMMUNOLOGIC RESEARCH
- Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
- (2013) Christian Klein et al. mAbs
- Microbials for the production of monoclonal antibodies and antibody fragments
- (2013) Oliver Spadiut et al. TRENDS IN BIOTECHNOLOGY
- Fusion protein linkers: Property, design and functionality
- (2012) Xiaoying Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Brentuximab Vedotin
- (2012) C. Deng et al. CLINICAL CANCER RESEARCH
- Quantum Dot- Conjugated Anti-GRP78 scFv Inhibits Cancer Growth in Mice
- (2012) Weiming Xu et al. MOLECULES
- Monoclonal antibodies for the treatment of cancer
- (2012) Casey W. Shuptrine et al. SEMINARS IN CANCER BIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Understanding and circumventing resistance to anticancer monoclonal antibodies
- (2010) Lina Reslan et al. mAbs
- Epitope mapping and key amino acid identification of anti-CD22 immunotoxin CAT-8015 using hybrid -lactamase display
- (2010) D. Bannister et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Molecular Modeling and Affinity Determination of scFv Antibody: Proper Linker Peptide Enhances Its Activity
- (2009) Xin Gu et al. ANNALS OF BIOMEDICAL ENGINEERING
- Panitumumab
- (2009) Eline A. Dubois et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
- (2009) Royston Jefferis TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More